Corporate DisclosureNAVANAPHAR
NAVANAPHAR Corporate Disclosure — 5 December 2022
Announcement summary
- What happened
- NAVANAPHAR published a corporate disclosure on 5 December 2022. Read the full announcement for details.
- Company
- Navana Pharmaceuticals PLC
- Announcement published
Original announcement
National Credit Ratings Limited (NCR) has assigned the surveillance entity rating of the Company as "AA" in the long term and "ST-2" in the short term along with a stable outlook based on audited financial statements of the Company as on June 30, 2022.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 638d6721b2c25841941b07b9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from NAVANAPHAR
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.